Top Picks For 2023: Centene Corporation

Blue and Silver Stetoscope

Image Source: Pexels

Centene Corporation (CNC) — a top pick for 2023 — is an international healthcare company. The firm offers services to government-sponsored and commercial healthcare providers, notes John Staszak, an analyst with Argus Research.

Centene, based in St. Louis, has an emphasis on under-insured and uninsured individuals. The company is the largest Medicaid managed care organization in the U.S. and a leading provider of insurance under the Affordable Care Act.

The company has grown primarily through the acquisition of other health plans and services, including Magellan Health Care for $2.2 billion in January 2022, and Medicare insurer WellCare for $19.6 billion in January 2020.

Management now projects EPS of $5.65-$5.75, up from a prior $5.60-$5.75. This is the fourth time throughout the past year that management has raised guidance.

Reflecting recent contract wins in North Carolina, management's guidance, and positive earnings surprises in five of the past six quarters, we are keeping our EPS estimates at $6.00 for 2022 and $6.80 for 2023. Our long-term earnings growth rate estimate is 15%.

We think that CNC shares are attractively valued at recent prices, above the midpoint of their 52-week range of $61-$99. On a technical basis, the shares have been in a long-term bullish pattern of higher highs and higher lows that dates back to September 2019, though they have fallen sharply with the market since mid-August.

On a fundamental basis, the shares have been trading at about 12.7-times our 2023 EPS estimate, near the midpoint of the historical range of 10-16. Compared to the peer group, the shares have recently been trading at below-average multiples, which we think is unwarranted given the company's strong growth prospects. We are maintaining our "buy" rating and raising our target price to $99.


About the Author

John Staszak's specialty at Argus includes the gaming, lodging, and restaurant groups within the consumer discretionary sector. Mr. Staszak earned an MBA from the University of Texas and a BA in economics from the University of Pennsylvania. In the financial services industry, he has worked as an analyst and consultant for firms including Standard & Poor's, the Bank of New York, Harris Nesbitt Gerard, and Merrill Lynch.

Mr. Staszak is a CFA charterholder. Forbes magazine named him as the second-best stock picker among restaurant analysts in 2006. He was also ranked the second-best analyst covering the restaurant sector by The Wall Street Journal in 2007, a year in which a Financial Times/StarMine survey also ranked him that same way.

In 2008, the Journal again listed Mr. Staszak as an award winner, with a third-best designation among hotel industry analysts and a fifth-best designation among restaurant analysts.


More By This Author:

Top Picks 2023: Baker Hughes
Top Picks For 2023: Catalyst Pharmaceuticals - Sunday, Jan. 8
Top Picks For 2023: Lockheed Martin

Disclaimer: © 2023 MoneyShow.com, LLC. All Rights Reserved.

How did you like this article? Let us know so we can better customize your reading experience.

Comments